secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2022-07-27T23:59:59+00:00
Accession:  0001562762-22-000302
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q2 adj EPS $4.84, raises FY22 guidance low-end to $19.30; Roto-Rooter revenue +6%
--------------------------------------------------------------------------------

- Revenue $531M, down 0.2% YoY; GAAP diluted EPS $4.40 (+25.4%); adjusted diluted EPS $4.84 (+5.2%).
- VITAS revenue $298M (-4.5%); ADC 17,315 (-3.8%); admissions -12.5%; adj EBITDA margin 16.7% (-78bps).
- Roto-Rooter revenue $233M (+6.0%); adj EBITDA $69.0M (+7.4%); margin 29.6% (+39bps).
- FY2022 adjusted EPS guidance raised to $19.30-$19.50 from $19.10-$19.50; VITAS rev. decline 4.5-5.0%, Roto-Rooter growth 5.5-5.7%.
- Repurchased 100,000 shares for $49.9M at avg $498.61; entered new $550M credit agreement in June.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276222000302/0001562762-22-000302-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276222000302/che-20220727x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000302

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer